Clinical Trial Update: A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating concurrent chemoradiotherapy with cisplatin with or without sintilimab as first-line therapy for advanced oral cavity squamous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Cavity Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Sintilimab (sintilimab)

Snippet

Sponsor: Xin-Hua Xu | Conditions: Oral Cavity Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN